OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The protective nasal boosting of a triple-RBD subunit vaccine against SARS-CoV-2 following inactivated virus vaccination
Jingyi Yang, Meiqin Liu, Lin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Jingyi Yang, Meiqin Liu, Lin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
An Intranasal Multivalent Epitope-Based Nanoparticle Vaccine Confers Broad Protection against Divergent Influenza Viruses
Jingdi Pan, Qihui Wang, Mi Qi, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13474-13487
Closed Access | Times Cited: 29
Jingdi Pan, Qihui Wang, Mi Qi, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13474-13487
Closed Access | Times Cited: 29
Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants
Shuqi Wang, Peiyang Ding, Lingli Shen, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Shuqi Wang, Peiyang Ding, Lingli Shen, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1
Xian Li, Mengxin Xu, Jingyi Yang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Xian Li, Mengxin Xu, Jingyi Yang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
Ming Zhou, Haihua Xiao, Xinyi Yang, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
Ming Zhou, Haihua Xiao, Xinyi Yang, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
High-throughput modular click chemistry synthesis of catechol derivatives as covalent inhibitors of SARS-CoV-2 3CLpro
Feng Wang, Tiancheng Ma, Donglan Liu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 1
Feng Wang, Tiancheng Ma, Donglan Liu, et al.
Acta Materia Medica (2024) Vol. 3, Iss. 3
Open Access | Times Cited: 1
DNA Prime-Protein Boost Targeting Conformational Non-RBD Region for Broad Cross-Neutralization
Yun-Fei Ma, Kun Chen, Bowen Xie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Yun-Fei Ma, Kun Chen, Bowen Xie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Enhanced Antibody Response to the Conformational Non-RBD Region via DNA Prime-Protein Boost Elicits Broad Cross-Neutralization Against SARS-CoV-2 Variants
Yun-Fei Ma, Kun Chen, Bowen Xie, et al.
Emerging Microbes & Infections (2024)
Open Access
Yun-Fei Ma, Kun Chen, Bowen Xie, et al.
Emerging Microbes & Infections (2024)
Open Access
Effectiveness of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2.2 Infection in Beijing, China, 2022: A Cohabitation Retrospective Cohort Study
Shuaibing Dong, Ying Sun, Zhaomin Feng, et al.
Viruses (2024) Vol. 17, Iss. 1, pp. 31-31
Open Access
Shuaibing Dong, Ying Sun, Zhaomin Feng, et al.
Viruses (2024) Vol. 17, Iss. 1, pp. 31-31
Open Access
